| PVR | Plasma BNP | Peak VO2 |
---|
r
|
P
|
r
|
P
|
r
|
P
|
---|
PF | −0.500 | <0.001 | −0.496 | <0.001 | 0.501 | <0.001 |
RP | −0.529 | <0.001 | −0.513 | <0.001 | 0.657 | <0.001 |
BP | 0.050 | 0.754 | −0.125 | 0.436 | 0.179 | 0.263 |
GH | −0.455 | 0.003 | −0.327 | 0.037 | 0.396 | 0.010 |
VT | −0.390 | 0.012 | −0.529 | <0.001 | 0.531 | <0.001 |
SF | −0.272 | 0.086 | −0.349 | 0.025 | 0.427 | 0.005 |
RE | −0.337 | 0.031 | −0.428 | 0.005 | 0.494 | 0.001 |
MH | −0.134 | 0.402 | −0.213 | 0.181 | 0.211 | 0.186 |
PCS | −0.427 | 0.005 | −0.417 | 0.007 | 0.411 | 0.003 |
MCS | −0.158 | 0.323 | −0.280 | 0.076 | 0.299 | 0.037 |
- PVR Pulmonary vascular resistance, BNP Brain natriuretic peptide
- Health-related quality of life was assessed by using the Medical Outcomes Study Short Form Health Survey (SF-8), which consists of eight items, each representing one health profile dimension: PF Physical functioning; RP Role functioning – physical, BP Bodily pain, GH General health perception, VT Vitality, SF Social functioning, RE Role functioning – emotional; and MH Mental health. Physical component summary (PCS) and mental component summary (MCS) scores were compared with demographically adjusted United States norms and with historical controls